Lori Anne Kunkel is of Oric Pharmaceuticals, Inc.. Currently has a direct ownership of 84,200 shares of ORIC, which is worth approximately $1.1 Million. The most recent transaction as insider was on Dec 08, 2025, when has been sold 10,000 shares (Common Stock) at a price of $7.9 per share, resulting in proceeds of $79,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.2K
22.62% 3M change
310.73% 12M change
Total Value Held $1.1 Million

Lori Anne Kunkel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2025
BUY
Exercise of conversion of derivative security
$79,000 $7.9 p/Share
10,000 Added 10.62%
84,200 Common Stock
Dec 04 2025
BUY
Exercise of conversion of derivative security
$20,752 $3.75 p/Share
5,534 Added 6.94%
74,200 Common Stock
Mar 03 2025
BUY
Exercise of conversion of derivative security
$242,756 $5.04 p/Share
48,166 Added 41.23%
68,666 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$76,875 $3.75 p/Share
20,500 Added 50.0%
20,500 Common Stock

Also insider at

NRIX
Nurix Therapeutics, Inc. Healthcare
CRIS
CURIS INC Healthcare
IMRA
IMARA Inc. Healthcare
LAK

Lori Anne Kunkel

San Francisco, CA

Track Institutional and Insider Activities on ORIC

Follow Oric Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC